Boussard & Gavaudan Investment Management LLP Q4 2019 Filing

Filed February 12, 2020

Portfolio Value

$449.3B

Holdings

22

Report Date

Q4 2019

Filing Type

13F-HR

All Holdings (22 positions)

#StockSharesValue% PortfolioType
1
Allergan PLC
1,323,402$252.2B56.13%
2
CSTMConstellium NV
3,396,034$45.9B10.21%
3
ASHASHLAND GLOBAL HOLDINGS INC
345,823$26.4B5.87%
4
LBRDKLIBERTY BROADBAND-C
189,984$23.8B5.29%
5
TALLGRASS ENERGY LP
496,411$11.0B2.44%
6
Silver Spike Acquisition
900,000$9.2B2.04%
7
Experience Investment Ut
900,000$9.0B2.01%
8
Diamond Eagle Common
803,270$8.5B1.90%
9
Thunder Bridge Acquisition II
800,000$8.3B1.85%
10
Osprey Technology Acquisition
800,000$8.1B1.81%
11
QIAGEN N.V.
216,938$7.3B1.62%
12
Landcadia Hldgs Uts
651,900$6.6B1.47%
13
PARSLEY ENERGY INC-CLASS A
351,581$6.6B1.47%
14
SC Health Corp
600,000$6.2B1.38%
15
Alussa Energy Acquisition Corp
550,000$5.5B1.24%
16
Oaktree Acquisition
400,000$4.1B0.91%
17
New Providence Uts
300,000$3.1B0.69%
18
SSFSENSIENT TECHNOLOGIES CORP
34,260$2.3B0.50%
19
Churchill Cap Uts
200,000$2.2B0.48%
20
Conyers Park II Acquisition
150,000$1.6B0.37%
21
Diamond Eagle Warrant
334,423$782.0M0.17%
22
BMY-RCELGENE CVR
226,120$690.0M0.15%